Cécile Tomowiak

1.2k total citations
45 papers, 404 citations indexed

About

Cécile Tomowiak is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Cécile Tomowiak has authored 45 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 24 papers in Pathology and Forensic Medicine and 13 papers in Hematology. Recurrent topics in Cécile Tomowiak's work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (24 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Cécile Tomowiak is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (24 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Cécile Tomowiak collaborates with scholars based in France, United States and Australia. Cécile Tomowiak's co-authors include Xavier Leleu, Stéphanie Guidez, Stéphanie Poulain, Charles Herbaux, Véronique Leblond, Stéphane Leprêtre, Lydia Roy, François Guilhot, Thierry Langlois and Jason A. Mills and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Cécile Tomowiak

40 papers receiving 402 citations

Peers

Countries citing papers authored by Cécile Tomowiak

Since Specialization

Citations

This map shows the geographic impact of Cécile Tomowiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Tomowiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Tomowiak more than expected).

Fields of papers citing papers by Cécile Tomowiak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Tomowiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Tomowiak. The network helps show where Cécile Tomowiak may publish in the future.

Co-authorship network of co-authors of Cécile Tomowiak

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Tomowiak. A scholar is included among the top collaborators of Cécile Tomowiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Tomowiak. Cécile Tomowiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Waldenström’s macroglobulinemia: The LYSA pragmatic guidelines 2025 ·European Journal of Cancer ·Damien Roos‐Weil, Cécile Tomowiak, Stéphanie Poulain, Florence Nguyen‐Khac, (unknown), Marine Armand, Thérèse Aurran, Éric Durot, (unknown), Bénédicte Hivert, Kamel Laribi, (unknown), Stéphane Leprêtre, (unknown), (unknown), Laurence Simon, Véronique Leblond, Pierre Morel, Olivier Tournilhac	0
2	Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia 2024 ·Annals of Hematology ·Cécile Tomowiak, Stéphanie Poulain, (unknown), Pierre Feugier, Charles Herbaux, Beatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, (unknown), Damien Roos‐Weil, José Miguel Torregrosa Diaz, Sylvie Chevret, Véronique Leblond, (unknown)	2
3	Sipavibart (AZD-3152), a COVID-19 Pre-Exposure Prophylaxis in Myeloma Treated with BCMA/CD3 Bispecific Antibodies 2024 ·Blood ·(unknown), (unknown), Jean‐Marc Gombert, André Herbelin, Cécile Tomowiak, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aurélien Pichon, (unknown), (unknown), Nicolas Lévêque, Xavier Leleu, (unknown)	0
4	Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia 2023 ·Hematology/Oncology Clinics of North America ·Dipti Talaulikar, Cécile Tomowiak, Elise Toussaint, Pierre Morel, Prashant Kapoor, Jorge J. Castillo, Alain Delmer, Éric Durot	3
5	Transformed Waldenström Macroglobulinemia: Update on Diagnosis, Prognosis and Treatment 2022 ·SHILAP Revista de lepidopterología ·Éric Durot, Cécile Tomowiak, Elise Toussaint, Pierre Morel, Dipti Talaulikar, Prashant Kapoor, Jorge J. Castillo, Alain Delmer	1
6	Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients 2022 ·Cancers ·Elsa Maître, Cécile Tomowiak, (unknown), Fontanet Bijou, (unknown), (unknown), (unknown), Édouard Cornet, Pierre‐Julien Viailly, (unknown), Brigitte Sola, Fabrice Jardin, Xavier Troussard	10
7	Maladie de Waldenström : actualités et perspectives en 2022 2022 ·Bulletin du Cancer ·(unknown), (unknown), Véronique Leblond, Cécile Tomowiak, Kamel Laribi, Loïc Ysebaert, Olivier Tournilhac, Caroline Dartigeas, Stéphane Leprêtre, (unknown)	1
8	Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia 2021 ·Blood Advances ·Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Beatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, (unknown), Damien Roos‐Weil, Sylvie Chevret, Véronique Leblond	21
9	Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database 2021 ·Frontiers in Pharmacology ·(unknown), Cécile Tomowiak, (unknown), (unknown), Francesco Salvo	11
10	The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma 2020 ·Frontiers in Oncology ·(unknown), (unknown), (unknown), (unknown), Anthony Lévy, (unknown), (unknown), Cécile Tomowiak, José Miguel Torregrosa Diaz, Stéphanie Guidez, Xavier Leleu	4
11	Maladie de Waldenström 2019 ·La Presse Médicale ·Cécile Tomowiak, Stéphanie Poulain, (unknown), Stéphanie Guidez, Xavier Leleu	1
12	Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders 2019 ·Kidney International ·Vincent Javaugue, (unknown), (unknown), Elise Gand, Sophie Chauvet, Laure Écotière, Éstelle Desport, Jean‐Michel Goujon, Vincent Delwail, (unknown), Cécile Tomowiak, Xavier Leleu, Arnaud Jaccard, Nathalie Rioux-Leclerc, Cécile Vigneau, Jean‐Paul Fermand, (unknown), Antoine Thierry, Frank Bridoux	16
13	Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia 2018 ·Hematology/Oncology Clinics of North America ·(unknown), Cécile Tomowiak, Xavier Leleu, Stéphanie Poulain	5
14	Oral CHOP-like Chemotherapy in Elderly Patients with High-Grade Non Hodgkin B Cell Lymphoma 2018 ·Blood ·Stéphanie Guidez, Cécile Tomowiak, (unknown), Brigitte Dreyfus, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Xavier Leleu, Joëlle Guilhot, Vincent Delwail	1
15	TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia 2017 ·Clinical Cancer Research ·Stéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, Aline Renneville, (unknown), (unknown), Sandrine Geffroy, Shéhérazade Sebda, Olivier Nibourel, (unknown), Charles Herbaux, Loïc Renaud, Cécile Tomowiak, Stéphanie Guidez, Sabine Tricot, Catherine Roche‐Lestienne, Bruno Quesnel, Claude Preudhomme, Xavier Leleu	62
16	Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis 2016 ·Biology of Blood and Marrow Transplantation ·Florence Rabian, Raphaël Porcher, Flore Sicre de Fontbrune, Bruno Lioure, (unknown), Stéphanie Nguyen, Reza Tabrizi, Stéphane Vigouroux, Cécile Tomowiak, (unknown), Felipe Suárez, Jérémy Delage, Régis Peffault de Latour, Gérard Socié	7
17	Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia 2014 ·Blood ·Iléana Antony‐Debré, (unknown), Nathalie Balayn, Dominique Bluteau, Cécile Tomowiak, Céline Legrand, Thierry Langlois, Olivia Bawa, Lucie Tosca, Gérard Tachdjian, Bruno Leheup, Najet Debili, Isabelle Plo, Jason A. Mills, Deborah L. French, Mitchell J. Weiss, Éric Solary, Rémi Favier, William Vainchenker, Hana Raslová	71
18	Long‐term follow‐up and second malignancies in 487 patients with hairy cell leukaemia 2014 ·British Journal of Haematology ·Édouard Cornet, Cécile Tomowiak, Aline Schmidt, Stéphane Leprêtre, Jehan Dupuis, Pierre Feugier, Alain Devidas, Clara Mariette, Véronique Leblond, Catherine Thiéblemont, (unknown), Laurent Sutton, Emmanuel Gyan, Jean‐Claude Eisenmann, Pascale Cony‐Makhoul, Loïc Ysebaert, Xavier Troussard, (unknown)	42
19	Current treatment strategies in chronic myeloid leukemia 2012 ·Current Opinion in Hematology ·François Guilhot, Lydia Roy, Cécile Tomowiak	12
20	Critères d'éligibilité des patients pour un traitement par immunoglobuline humaine normale intraveineuse 2007 ·La Revue de Médecine Interne ·Patrick Feugier, Cécile Tomowiak, Nicolas Daguindau, Aurore Perrot	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact